Outcome of 12-weeks Triple Therapy (TT), including Sofosbuvir (SOF), Ribavirin and Pegylated interferon-Alfa in all non-cirrhotic patients with chronic Hepatitis-C Genotype-3 infection. mfm. 2024;28(7). Accessed November 16, 2025. https://medicalforummonthly.com/index.php/mfm/article/view/4148